Study in Subjects Undergoing Complete Abdominoplasty
Completed · Phase 2 · Has a placebo group
Conditions studied: Postsurgical Pain
In brief
Phase 2, single center, randomized, double-blind, placebo-controlled, parallel design study of CA-008 vs. placebo in subjects undergoing an elective C-ABD under general anesthesia supplemented with a bupivacaine hydrochloride (HCl)transverse abdominis plane (TAP) block.
Key facts
- Study ID
- NCT03789318
- Run by
- Concentric Analgesics
- People needed
- 54
- Starts
- 2018-12-03
- Expected to finish
- 2019-06-12
- Last updated by the study team
- 2024-03-19
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Lotus Clinical Research, LLC — Pasadena, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.